Sylvia E. Rosas

May 6, 2024 | opmed.doximity.com | Sylvia E. Rosas |Hardeep Phull |Teresa Samson |Christopher Bondoc

Dr. Sylvia Rosas is a nephrologist and epidemiologist at the Joslin Diabetes Center in Boston, MA. She is the Director of the Latino Kidney Clinic and an Associate Professor of Medicine at Harvard Medical School. She also is a nephrologist at the Beth Israel Deaconess Medical Center and currently sits as the President of the National Kidney Foundation.

Apr 3, 2024 | nature.com | Paola Fioretto |Frederik Persson |Sylvia E. Rosas |Peter Rossing |Jennifer Schaub |Katherine R. Tuttle | +1 more

AbstractDiabetic kidney disease (DKD), defined as co-existing diabetes and chronic kidney disease in the absence of other clear causes of kidney injury, occurs in approximately 20–40% of patients with diabetes mellitus. As the global prevalence of diabetes has increased, DKD has become highly prevalent and a leading cause of kidney failure, accelerated cardiovascular disease, premature mortality and global health care expenditure.

Aug 7, 2023 | nature.com | Sylvia E. Rosas

Racial and ethnic minoritized populations are underrepresented in clinical trials in nephrology, but overrepresented in adverse kidney disease outcomes. Targeted enrolment, revision of problematic policies, inclusion of minoritized populations in trial planning, and language-, race- and ethnicity-concordant investigative teams can improve representation in clinical trials. Refers to Soomro, Q. H. et al.